US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.
Zacks.com on MSN22h
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?UnitedHealth Group Incorporated UNH is currently viewed as expensive ... UnitedHealth’s health service business, ...
UnitedHealth Group's Optum Rx will join its peers in the big three pharmacy benefit managers by pulling Humira from some of ...
UnitedHealth's aggressive M&A strategy and focus on data analytics drive growth and margin improvements, justifying a 'Strong ...
The Times wants to hear from patients and providers about medical practices affiliated with Optum, a subsidiary of UnitedHealth Group. Share your experience below. By Chris Hamby Several ...
About 50 people gathered in Eden Prairie to allege biggest players in industry are ballooning drug costs while running ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback